首页> 外国专利> CARBOSTYRIL DERIVATIVES AND MOOD STABILIZERS FOR TREATING MOOD DISORDERS

CARBOSTYRIL DERIVATIVES AND MOOD STABILIZERS FOR TREATING MOOD DISORDERS

机译:碳水化合物衍生物和情绪稳定剂治疗情绪障碍

摘要

The pharmaceutical composition of the present invention comprises a carbostyril derivative which is a dopamine-serotonin system stabilizer and a mood stabilizer in a pharmaceutically acceptable carrier. The carbostyril derivative may be aripiprazole or a metabolite thereof. The mood stabilizer may include but is not limited to lithium, valproic acid, divalproex sodium, carbamazapine, oxcarbamazapine, zonisamide, lamotragine, topiramate, gabapentin, levetiracetam or clonazepam. These compositions are used to treat patients with mood disorders, particularly bipolar disorder with or without psychotic features, mania or mixed episodes. Methods are provided for separate administration of a carbostyril derivative and a mood stabilizer to a patient with a mood disorder.
机译:本发明的药物组合物在药学上可接受的载体中包含作为多巴胺-5-羟色胺系统稳定剂和心情稳定剂的卡斯丁尔衍生物。卡波斯蒂利衍生物可以是阿立哌唑或其代谢物。情绪稳定剂可包括但不限于锂,丙戊酸,双丙戊酸钠,卡马氮平,奥卡马平,唑尼沙胺,拉莫拉金,托吡酯,加巴喷丁,左乙拉西坦或氯硝西am。这些组合物用于治疗患有情绪障碍,特别是患有或没有精神病性特征,躁狂症或混合发作的躁郁症的患者。提供了向患有情绪障碍的患者分开施用卡斯丁腈衍生物和情绪稳定剂的方法。

著录项

  • 公开/公告号US2020246332A1

    专利类型

  • 公开/公告日2020-08-06

    原文格式PDF

  • 申请/专利权人 OTSUKA PHARMACEUTICAL CO. LTD.;

    申请/专利号US201916576806

  • 申请日2019-09-20

  • 分类号A61K31/496;A61K31/5513;A61K31/53;A61K31/423;A61K31/4015;A61K31/357;A61K45/06;A61K33/14;A61K33;A61K31/7008;A61K31/55;A61K31/497;A61K31/4704;A61K31/425;A61K31/195;A61K31/19;

  • 国家 US

  • 入库时间 2022-08-21 11:21:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号